Supporting these observations, previous studies have shown that CCRL2 can modulate innate immune signaling via direct interactions with receptors such as TLR4, enhancing its plasma membrane stability and promoting MyD88-dependent NF-κB signaling in tumor-associated macrophages [27] (Figure 6G). The gene discussed is CCRL2; the disease is neoplasm.